Trial reportHaematologica2018
The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial.
Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph
Trial report in Haematologica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 32 citations in OpenAlex.
- Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.Bone marrow transplantation · 2026Observational
- Patient-reported outcomes in chronic GVHD: instruments, clinical utility, and survivorship integration.Journal of patient-reported outcomes · 2026Review
- Digital health technology use in clinical trials of rare diseases: a systematic review.Communications medicine · 2025Article
- NIH Chronic Graft-Versus-Host Disease Consensus Conference 2025 Update.Transplantation and cellular therapy · 2025Review
- aGvHDtrackR and cGvHDtrackR: shiny applications for graft versus host disease management and clinical data collection.Bone marrow transplantation · 2025Article
- Modern-Era Challenges in the Clinical Management of Graft-Versus-Host Disease.Advances in experimental medicine and biology · 2025Review
- Data-driven grading of acute graft-versus-host disease.Nature communications · 2023Article
- Methods used to evaluate usability of mobile clinical decision support systems for healthcare emergencies: a systematic review and qualitative synthesis.JAMIA open · 2023Review
- Acute graft-versus-host disease.Nature reviews. Disease primers · 2023Review
- BleedHD-a new electronic assessment tool for grading chronic graft-versus-host disease validated in a multicenter and multiprofessional setting.Bone marrow transplantation · 2023Article
- Utility of eGVHD App for bedside GVHD assessment in a high-volume BMT center.Blood cell therapy · 2023Article
- Development and Use of a Cardiac Clinical Guideline Mobile App in Australia: Acceptability and Multi-Methods Study.JMIR formative research · 2022Article
- Expanding Personalized, Data-Driven Dermatology: Leveraging Digital Health Technology and Machine Learning to Improve Patient Outcomes.JID innovations : skin science from molecules to population health · 2022Review
- Methods to Assess Disease Activity and Severity in Cutaneous Chronic Graft-versus-Host Disease: A Critical Literature Review.Transplantation and cellular therapy · 2021Review
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report.Transplantation and cellular therapy · 2021Article
- Acute GVHD Diagnosis and Adjudication in a Multicenter Trial: A Report From the BMT CTN 1202 Biorepository Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021Observational
- Patient-reported outcomes in acute graft-versus-host disease: optimizing patient care and clinical trial endpoints.Bone marrow transplantation · 2020Review
- Review
- How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Frontiers in immunology · 2020Review
- Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT - A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party.Frontiers in immunology · 2020Article
Corrections and comments
- Commented on by
Authors and funding
20 authors at 13 institutions in 6 countries.
Helene M SchoemansDepartment of Hematology, University Hospitals Leuven and KU Leuven, Belgium helene.schoemans@uzleuven.be.
Kathy GorisDepartment of Hematology, University Hospitals Leuven and KU Leuven, Belgium.
Raf Van DurmIT Department, University Hospitals Leuven, KU Leuven, Belgium.
Steffen FieuwsL-BioStat, KU Leuven - University of Leuven & Universiteit Hasselt, Leuven, Belgium.
Sabina De GeestAcademic Centre for Nursing and Midwifery, KU Leuven, Belgium.
Steven Z PavleticExperimental Transplantation and Immunology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.
Annie ImUniversity of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Daniel WolffDepartment of Hematology and Clinical Oncology, University of Regensburg, Germany.
Stephanie J LeeClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Hildegard GreinixDivision of Hematology, Medical University of Graz, Austria.
Rafael F DuarteICO/Hospital Duran I Reynals, Hospitalet De Llobregat, Spain.
Xavier PoiréCliniques Universitaires Saint-Luc, Brussels, Belgium.
Dominik SelleslagDepartment of Hematology, AZ Sint-Jan Brugge, Belgium.
Philippe LewalleInstitut Jules Bordet - Université Libre de Bruxelles, Belgium.
Tessa KerreHematology and Stem Cell Transplantation, Ghent University Hospital, Belgium.
Carlos GrauxUniversité Catholique de Louvain, CHU UCL Namur (Godinne site), Yvoir, Belgium.
Frédéric BaronHematology, University of Liège, GIGA-I3, Belgium.
Johan A MaertensDepartment of Hematology, University Hospitals Leuven and KU Leuven, Belgium.
Fabienne DobbelsAcademic Centre for Nursing and Midwifery, KU Leuven, Belgium.
EBMT Transplantation Complications Working party
KU Leuven · BEAZ Sint-Jan · BECliniques Universitaires Saint-Luc · BEDuran i Reynals Hospital · ESFred Hutch Cancer Center · USGhent University Hospital · BEMedical University of Graz · ATNational Cancer Institute · USUCLouvain · BEUniversité Libre de Bruxelles · BEUniversity of Liège · BEUniversity of Pittsburgh Medical Center · USUniversity of Regensburg · DE
Funding
NIH Chronic GVHD Study GroupZIABC011743 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI PAVLETIC, STEVEN · 2016 to 2025
$10.2MAbstract
Graft-
Indexed as
Health PersonnelMobile ApplicationsAdultFemaleGraft vs Host DiseaseHumansMaleMiddle Aged
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.